Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer
Condition: Advanced Ovarian Cancer Interventions: Biological: AST-201; Drug: Paclitaxel; Drug: Carboplatin; Drug: Placebo; Drug: rhuGM-CSF(Granulocyte-Macrophage Colony-Stimulating Factor) Sponsor: Aston Sci. Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Ovarian Cancer | Ovaries | Research | Vaccines